N-Linked Glycosylation in Chinese Hamster Ovary Cells Is Critical for Insulin-like Growth Factor 1 Signaling.
Salvi. Rupashree R; Kumar. Chandan C; Brahmbhatt. Krupanshi K; Subedi. Rambhadur R; Idicula-Thomas. Susan S; Madan. Taruna T; Biswas. Barnali B
Key Findings
- Loss of N‑glycosylation in CHO cells dramatically lowers surface IGF‑1R levels
- Reduced IGF‑1R leads to weaker ERK1/2 phosphorylation after IGF‑1 LR3 stimulation
- IQGAP1 may serve as a scaffold linking IGF‑1R to ERK signaling, and its interaction requires proper glycosylation via MGAT1 and MGAT5
Practical Outcomes
- Support your body’s glycosylation pathways (e.g., adequate nutrition for N‑glycan synthesis) to help maintain IGF‑1 receptor function. If glycosylation is compromised, IGF‑1 LR3 may be less effective, so consider overall metabolic health alongside peptide dosing.
Summary
The study shows that cells need proper N‑glycosylation to make enough IGF‑1 receptors on their surface, and without it, the IGF‑1 LR3 hormone can’t trigger the downstream ERK signaling as well. This suggests that the effectiveness of IGF‑1 LR3 depends on the cell’s glycosylation machinery, not just the dose of the peptide.
Abstract
Cell surface proteins carrying N-glycans play important roles in inter- and intracellular processes including cell adhesion, development, and cellular recognition. Dysregulation of the glycosylation machinery has been implicated in various diseases, and investigation of global differential cell surface proteome effects due to the loss of N-glycosylation will provide comprehensive insights into their pathogenesis. Cell surface proteins isolated from Parent Pro<sup>-5</sup> CHO cells (W5 cells), two CHO mutants with loss of N-glycosylation function derived from Pro<sup>-5</sup> CHO (Lec1 and Lec4 cells), were subjected to proteome analysis via high-resolution LCMS. We identified 44 and 43 differentially expressed membrane proteins in Lec1 and Lec4 cells, respectively, as compared to W5 cells. The defective N-glycosylation mutants showed increased abundance of integrin subunits in Lec1 and Lec4 cells at the cell surface. We also found significantly reduced levels of IGF-1R (Insulin like growth factor-1 receptor); a receptor tyrosine kinase; and the GTPase activating protein IQGAP1 (IQ motif-containing GTPase activating protein), a highly conserved cytoplasmic scaffold protein) in Lec1 and Lec4 cells. In silico docking studies showed that the IQ domain of IQGAP1 interacts with the kinase domain of IGF-1R. The integrin signaling and insulin growth factor receptor signaling were also enriched according to GSEA analysis and pathway analysis of differentially expressed proteins. Significant reductions of phosphorylation of ERK1 and ERK2 in Lec1 and Lec4 cells were observed upon IGF-1R ligand (IGF-1 LR3) stimulation. IGF-1 LR3, known as Long arginine3-IGF-1, is a synthetic protein and lengthened analog of insulin-like growth factor 1. The work suggests a novel mechanism for the activation of IGF-1 dependent ERK signaling in CHO cells, wherein IQGAP1 plausibly functions as an IGF-1R-associated scaffold protein. Appropriate glycosylation by the enzymes MGAT1 and MGAT5 is thus essential for processing of cell surface receptor IGF-1R, a potential binding partner in IQGAP1 and ERK signaling, the integral components of the IGF pathway.
Study Information
pubmed
2022
2022-11-29T00:00:00.000Z
10.3390/ijms232314952
4
88